Cosmo Oil

Cosmo Oil, a core subsidiary of Cosmo Energy Holdings, is a major Japanese energy conglomerate that has established a unique and significant presence in the life sciences through its pioneering work in biotechnology. The company is globally recognized for developing a proprietary fermentation process for the mass production of 5-aminolevulinic acid (5-ALA), a naturally occurring amino acid with vital applications in oncology and metabolic health. This innovation led to the commercialization of photodynamic diagnostic agents used to visualize cancerous tissues during surgeries for bladder cancer and brain tumors. Beyond its pharmaceutical contributions, Cosmo Oil leverages its biotech expertise to research microalgae-based biofuels as part of its commitment to sustainable energy transitions. While the company divested its primary healthcare unit to SBI Holdings in 2022, it remains a key historical and technological contributor to the global 5-ALA market.